XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:        
Net income (loss) $ 799 $ 14,856 $ 425 $ 17,422
Adjustments to reconcile net income to cash flow from operating activities:        
Depreciation and amortization 15,231 12,721 30,059 25,168
Amortization of deferred financing costs     723 701
Stock compensation expense     3,859 1,708
Gain on sale of assets   (12,142)   (12,142)
Casualty losses 411   411  
Amortization related to derivative instruments     579 231
Changes in assets and liabilities:        
Other assets     (4,348) 369
Accounts payable and accrued expenses     2,812 2,445
Accrued interest payable     (188) (27)
Other liabilities     7 225
Net cash provided by operating activities     34,339 36,100
Cash flows from investing activities:        
Acquisition of real estate properties     (50,618) (28,981)
Disposition of real estate properties       20,761
Capital expenditures     (17,070) (19,932)
Cash flow used in investing activities     (67,688) (28,152)
Cash flows from financing activities:        
Proceeds from unsecured credit facility and term loans     65,501 104,060
Unsecured credit facility repayments     (39,000) (79,000)
Mortgage principal repayments     (3,835) (1,987)
Payments for deferred financing costs     (50) (984)
Proceeds from issuance of common stock     49,732 6,032
Distributions on common stock     (33,479) (32,316)
Distributions to noncontrolling interests     (302) (323)
Repurchase of shares related to equity award tax withholding     (1,490) (635)
Cash flow provided by (used in) financing activities     37,077 (5,153)
Net change in cash and cash equivalents, and restricted cash     3,728 2,795
Cash and cash equivalents, and restricted cash, beginning of period     14,433 16,045
Cash and cash equivalents, and restricted cash, end of the period 18,161 18,840 18,161 18,840
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheet        
Cash and cash equivalents 11,652 11,060 11,652 11,060
Restricted cash 6,509 7,780 6,509 7,780
Cash and cash equivalents, and restricted cash, end of the period $ 18,161 $ 18,840 $ 18,161 $ 18,840